AKAmanda J. Kull

Amanda J. Kull

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amanda J. Kull has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Donald Cannon

    Department of Radiation Oncology, The University of Utah School of Medicine, Salt Lake City, Utah

    1 shared publication
  • Jason P. Hunt

    Otolaryngology Head and Neck Surgery, The University of Utah School of Medicine, Salt Lake City, Utah

    1 shared publication
  • Jeffrey J. Houlton

    Department of Otolaryngology-Head and Neck Surgery, University of Washington, Washington

    1 shared publication
  • John R. Weis

    Division of Oncology, The University of Utah School of Medicine, Salt Lake City, Utah

    1 shared publication
  • Luke O. Buchmann

    Otolaryngology Head and Neck Surgery, The University of Utah School of Medicine, Salt Lake City, Utah

    1 shared publication
  • Marcus M. Monroe

    Otolaryngology Head and Neck Surgery, The University of Utah School of Medicine, Salt Lake City, Utah

    1 shared publication

Latest Publications

  • Adjuvant radiation for positive margins in adult head and neck sarcomas is associated with improved survival: Analysis of the National Cancer Database

    by Richard B. Cannon, Amanda J. Kull, Patrick S. Carpenter, Sam Francis, Luke O. Buchmann, Marcus M. Monroe, Shane Lloyd, Ying J. Hitchcock, Donald Cannon, John R. Weis, et al.

    Background: Adult head and neck (H&N) sarcomas are a rare malignancy with limited data delineating the role of postoperative radiotherapy (PORT), particularly for a positive surgical margin. There are no randomized trials supporting the use of PORT, therefore treatment trends vary between institutions. A positive margin predicts recurrence and poor survival outcomes. This study uses the National Cancer Database (NCDB) to investigate whether PORT improves overall survival (OS) in adult H&N sarcomas with a positive margin and how utilization has changed.Methods: Patients (n = 1142) in the NCDB from 2004‐2013 with adult H&N sarcomas who underwent resection and had a positive margin.Results: Factors significantly associated with increased utilization of PORT were: having insurance, salivary gland primary site, high‐risk histology, poor differentiation, and a macroscopic positive margin. Treatment with PORT was associated with improved 5‐year OS for all patients with a positive margin (57% vs 48%; P = .002), both microscopic (57% vs 49%; P = .010) and macroscopic (57% vs 41%; P = .036). Improved OS was significant after controlling for other known covariates on multivariate analysis (HR: 0.76; [0.64‐0.90]; P = .002). Treatment at a community‐based facility was an independent predictor for reduced OS (HR: 1.37; [1.15‐1.64]; P < .001). The percentage utilization (53%) of PORT for these patients did not change significantly over time.Conclusion: PORT provides a significant survival benefit for adult H&N sarcoma patients with either a microscopic or macroscopic positive margin; however, PORT is underutilized. Treatment at academic/research cancer programs was associated with increased utilization of PORT and improved survival outcomes.